Hypothyroidism and pregnancy

Endocrinologist

Volumn 12, Issue 5, 2002, Pages 454-464

  Smallridge, Robert C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROXINE;

AUTOIMMUNITY; CONGENITAL HYPOTHYROIDISM; FEMALE; HUMAN; HYPOTHYROIDISM; IODINE DEFICIENCY; MENTAL DEVELOPMENT; NEWBORN SCREENING; PREGNANCY; REVIEW; STRESS; THYROID FUNCTION; THYROXINE BLOOD LEVEL;

EID: 0036737440     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-200209000-00013     Document Type: Review

References (93)

1. Glinoer D, Delange F: The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid 2000; 10: 871-87.
2. Glinoer D: The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997; 18: 404-33.
3. Smallridge RC, Ladenson PW: Hypothyroidism in pregnancy: consequences to neonatal health. J Clin Endocrinol Metab 2001; 86: 2349-53.
4. Cao XY, Jiang XM, Dou ZH, et al.: Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. N Engl J Med 1994; 331: 1739-44.
5. Vulsma T, Gons MH, de Vijlder JJ: Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 1989; 321: 13-6.
6. Contempré B, Jauniaux E, Calvo R, et al.: Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab 1993; 77: 1719-22.
7. Calvo RM, Jauniaux E, Gulbis B, et al.: Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 2002; 87: 1768-77.
8. Morreale de Escobar G, Obregon MJ, Escobar del Rey F: Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 2000; 85: 3975-87.
9. Burrow GN, Fisher DA, Larsen PR: Maternal and fetal thyroid function. N Engl J Med 1994; 331: 1072-8.
10. Haddow JE, Palomaki GE, Allan WC, et al.: Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549-55.
11. Pop VJ, Kuijpens JL, van Baar AL, et al.: Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 1999; 50: 149-55.
12. Klein RZ, Haddow JE, Faix JD, et al.: Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) 1991; 35: 41-6.
13. Fukushi M, Honma K, Fujita K: Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child [letter]. N Engl J Med 1999; 341: 2016.
14. Montoro MN: Management of hypothyroidism during pregnancy. Clin Obstet Gynecol 1997; 40: 65-80.
15. Leung AS, Millar LK, Koonings PP, et al.: Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993; 81: 349-53.
16. Davis LE, Leveno KJ, Cunningham FG: Hypothyroidism complicating pregnancy. Obstet Gynecol 1988; 72: 108-12.
17. Wasserstrum N, Anania CA: Perinatal consequences of maternal hypothyroidism in early pregnancy and inadequate replacement. Clin Endocrinol (Oxf) 1995; 42: 353-8.
18. Abalovich M, Gutierrez S, Alcaraz G, et al.: Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002; 12: 63-8.
19. Allan WC, Haddow JE, Palomaki GE, et al.: Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000; 7: 127-30.
20. Pratt DE, Kaberlein G, Dudkiewicz A, et al.: The association of antithyroid antibodies in euthyroid nonpregnant women with recurrent first trimester abortions in the next pregnancy. Fertil Steril 1993; 60: 1001-5.
21. Stagnaro-Green A, Roman SH, Cobin RH, et al.: Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990; 264: 1422-5.
22. Singh A, Dantas ZN, Stone SC, et al.: Presence of thyroid antibodies in early reproductive failure: biochemical versus clinical pregnancies. Fertil Steril 1995; 63: 277-81.
23. Mecacci F, Parretti E, Cioni R, et al.: Thyroid autoimmunity and its association with non-organ-specific antibodies and subclinical alterations of thyroid function in women with a history of pregnancy loss or preeclampsia. J Reprod Immunol 2000; 46: 39-50.
24. Wilson R, Ling H, MacLean MA, et al.: Thyroid antibody titer and avidity in patients with recurrent miscarriage. Fertil Steril 1999; 71: 558-61.
25. Vaquero E, Lazzarin N, De Carolis C, et al.: Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach. Am J Reprod Immunol 2000; 43: 204-8.
26. Dowling AL, Martz GU, Leonard JL, et al.: Acute changes in maternal thyroid hormone induce rapid and transient changes in gene expression in fetal rat brain. J Neurosci 2000; 20: 2255-65.
27. Man EB, Brown JF, Serunian SA: Maternal hypothyroxinemia: psychoneurological deficits of progeny. Ann Clin Lab Sci 1991; 21: 227-39.
28. Smit BJ, Kok JH, Vulsma T, et al.: Neurologic development of the newborn and young child in relation to maternal thyroid function. Acta Paediatr 2000: 89: 291-5.
29. Liu H, Momotani N, Noh JY, et al.: Maternal hypothyroidism during early pregnancy and intellectual development of the progeny. Arch Intern Med 1994; 154: 785-7.
30. Mandel SJ, Larsen PR, Seely EW, et al.: Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 1990; 323: 91-6.
31. Dunn JT, Delange F: Damaged reproduction: the most important consequence of iodine deficiency. J Clin Endocrinol Metab 2001; 86: 2360-3.
32. Glinoer D: Pregnancy and iodine. Thyroid 2001; 11: 471-81.
33. Delange FM: Endemic cretinism. In: The Thyroid, edited by Braverman LE, Utiger RD, pp. 743-54. Philadelphia, Lippincott Williams & Wilkins 2000.
34. Boyages SC: The neuromuscular system and brain in hypothyroidism. In: Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, edited by Wemer SC, Ingbar SH, Braverman LE, et al., pp. 803-10. Philadelphia, Lippincott Williams & Wilkins 2000.
35. Pharoah PO, Connolly KJ, Ekins RP, et al.: Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clin Endocrinol (Oxf) 1984; 21: 265-70.
36. Vermiglio F, Lo Presti VP, Castagna MG, et al.: Increased risk of maternal thyroid failure with pregnancy progression in an iodine deficient area with major iodine deficiency disorders. Thyroid 1999; 9: 19-24.
37. Romano R, Jannini EA, Pepe M, et al.: The effects of iodoprophylaxis on thyroid size during pregnancy. Am J Obstet Gynecol 1991; 164: 482-5.
38. Pedersen KM, Laurberg P, Iversen E, et al.: Amelioration of some pregnancy-associated variations in thyroid function by iodine supplementation. J Clin Endocrinol Metab 1993; 77: 1078-83.
39. Glinoer D, De Nayer P, Delange F, et al.: A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. J Clin Endocrinol Metab 1995; 80: 258-69.
40. Kung AW, Lao TT, Chau MT, et al.: Goitrogenesis during pregnancy and neonatal hypothyroxinaemia in a borderline iodine sufficient area. Clin Endocrinol (Oxf) 2000; 53: 725-31.
41. Aghini Lombardi FA, Pinchera A, Antonangeli L, et al.: Mild iodine deficiency during fetal/neonatal life and neuropsychological impairment in Tuscany. J Endocrinol Invest 1995; 18: 57-62.
42. Dussault JH: Neonatal screening for congenital hypothyroidism. Clin Lab Med 1993; 13: 645-52.
43. Marchant B, Brownlie BE, Hart DM, et al.: The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab 1977; 45: 1187-93.
44. Mortimer RH, Cannell GR, Addison RS, et al.: Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 1997; 82: 3099-102.
45. Momotani N, Noh JY, Ishikawa N, et al.: Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab 1997; 82: 3633-6.
46. Eisenstein Z, Weiss M, Katz Y, et al.: Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. Eur J Pediatr 1992; 151: 558-9.
47. Mandel SJ, Cooper DS: The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 2001; 86: 2354-9.
48. Di Gianantonio E, Schaefer C, Mastroiacovo PP, et al.: Adverse effects of prenatal methimazole exposure. Teratology 2001; 64: 262-6.
49. Yasuda T, Ohnishi H, Wataki K, et al.: Outcome of a baby born from a mother with acquired juvenile hypothyroidism having undetectable thyroid hormone concentrations. J Clin Endocrinol Metab 1999; 84: 2630-2.
50. Matsuura N, Konishi J: Transient hypothyroidism in infants born to mothers with chronic thyroiditis-a nationwide study of twentythree cases. The Transient Hypothyroidism Study Group. Endocrinol Jpn 1990; 37: 369-79.
51. Fisher DA: Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Clin Obstet Gynecol 1997; 40: 16-31.
52. LaFranchi S: Congenital hypothyroidism: etiologies, diagnosis, and management. Thyroid 1999; 9: 735-40.
53. Van Vliet G: Neonatal hypothyroidism: treatment and outcome. Thyroid 1999; 9: 79-84.
54. Derksen-Lubsen G, Verkerk PH: Neuropsychologic development in early treated congenital hypothyroidism: analysis of literature data. Pediatr Res 1996; 39: 561-6.
55. Salerno M, Militerni R, Bravaccio C, et al.: Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism. Thyroid 2002; 12: 45-52.
56. Rovet JF: Congenital hypothyroidism: long-term outcome. Thyroid 1999; 9: 741-8.
57. Rovet JF, Ehrlich R: Psychoeducational outcome in children with early-treated congenital hypothyroidism. Pediatrics 2000; 105: 515-22.
58. Rovet JF: Long-term neuropsychological sequelae of early-treated congenital hypothyroidism: effects in adolescence. Acta Paediatr 1999; 88(Suppl432): 88-95.
59. Reuss ML, Paneth N, Pinto-Martin JA, et al.: The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996; 334: 821-7.
60. van Wassenaer AG, Kok JH, de Vijlder JJ, et al.: Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 1997; 336: 21-6.
61. Fisher DA: Hypothyroxinemia in premature infants: is thyroxine treatment necessary? Thyroid 1999; 9: 715-20.
62. Parry CH. Collections from the unpublished medical writings, vol 2, pp. 111-4. London, Underwoods 1825.
63. Roberton HEW: Lassitude, coldness, and hair changes following pregnancy, and their response to treatment with thyroid extract. BMJ 1948; 2(Suppl. Aug 28): 93-4.
64. Smallridge RC: Postpartum thyroid diseases through the ages: a historical view. Thyroid 1999; 9: 671-3.
65. Smallridge RC: Postpartum thyroid disease: A model of immunologic dysfunction. Clin Appl Immunol Rev 2000; 1: 89-103.
66. Smallridge RC: Postpartum thyroid dysfunction: A frequently undiagnosed endocrine disorder. The Endocrinologist 1996; 6: 44-50.
67. Amino N, Mori H, watani Y, et al.: High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N Engl J Med 1982; 306: 849-52.
68. Weetman AP: The immunology of pregnancy. Thyroid 1999; 9: 643-6.
69. Elenkov IJ, Wilder RL, Bakalov VK, et al.: IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 2001; 86: 4933-8.
70. Stagnaro-Green A, Roman SH, Cobin RH, et al.: A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab 1992; 74: 645-53.
71. Amino N, Tada H, Hidaka Y: Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid 1999; 9: 705-13.
72. Muller AF, Drexhage HA, Berghout A: Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 2001; 22: 605-30.
73. Solomon BL, Fein HG, Smallridge RC: Usefulness of antimicrosomal antibody titers in the diagnosis and treatment of postpartum thyroiditis. J Fam Pract 1993; 36: 177-82.
74. Hayslip CC, Fein HG, O'Donnell VM, et al.: The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. Am J Obstet Gynecol 1988; 159: 203-9.
75. Gerstein HC: Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus. Ann Intern Med 1993; 118: 419-23.
76. Alvarez-Marfany M, Roman SH, Drexler AJ, et al.: Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1994; 79: 10-6.
77. Fernandez-Soto L, Gonzalez A, Lobon JA, et al.: Thyroid peroxidase autoantibodies predict poor metabolic control and need for thyroid treatment in pregnant IDDM women. Diabetes Care 1997; 20: 1524-8.
78. Hughes JM, Ellsworth CA, Harris BS: Clinical case seminar: a 33-year-old woman with a pituitary mass and panhypopituitarism. J Clin Endocrinol Metab 1995; 80: 1521-5.
79. Bevan JS, Othman S, Lazarus JH, et al.: Reversible adrenocorticotropin deficiency due to probable autoimmune hypophysitis in a woman with postpartum thyroiditis. J Clin Endocrinol Metab 1992; 74: 548-52.
80. Stuckey BG, Kent GN, Allen JR: The biochemical and clinical course of postpartum thyroid dysfunction: the treatment decision. Clin Endocrinol (Oxf) 2001; 54: 377-83.
81. l. Harris B, Fung H, Johns S, et al.: Transient post-partum thyroid dysfunction and postnatal depression. J Affect Disord 1989; 17: 243-9.
82. Pop VJ, de Rooy HA, Vader HL, et al.: Postpartum thyroid dysfunction and depression in an unselected population [letter]. N Engl J Med 1991; 324: 1815-6.
83. Harris B, Othman S, Davies JA, et al.: Association between post-partum thyroid dysfunction and thyroid antibodies and depression. BMJ 1992; 305: 152-6.
84. Pop VJ, de Rooy HA, Vader HL, et al.: Microsomal antibodies during gestation in relation to postpartum thyroid dysfunction and depression. Acta Endocrinol (Copenh) 1993; 129: 26-30.
85. Pop VJ, Maartens LH, Leusink G, et al.: Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab 1998; 83: 3194-7.
86. Lucas A, Pizarro E, Granada ML, et al.: Postpartum thyroid dysfunction and postpartum depression: are they two linked disorders? Clin Endocrinol (Oxf) 2001; 55: 809-14.
87. Nikolai TF, Turney SL, Roberts RC: Postpartum lymphocytic thyroiditis: Prevalence, clinical course, and long-term follow-up. Arch Intern Med 1987; 147: 221-4.
88. Lazarus JH, Hall R, Othman S, et al. The clinical spectrum of post-partum thyroid disease. QJM 1996; 89: 429-35.
89. Lucas A, Pizarro E, Granada ML, et al.: Postpartum thyroiditis: epidemiology and clinical evolution in a nonselected population. Thyroid 2000; 10: 71-7.
90. Amino N, Tada H, Hidaka Y: Therapeutic controversy: Screening for postpartum thyroid dysfunction in the general population is beneficial. J Clin Endocrinol Metab 1999; 84: 1813-6.
91. Crapo LM: Screening for postpartum thyroiditis: The time is not ripe to screen. J Clin Endocrinol Metab 1999; 84: 1816-9.
92. Stagnaro-Green A: Postpartum thyroiditis: The case for selective screening. J Clin Endocrinol Metab 1999; 84: 1819-21.
93. Hollowell JG, Staehling NW, Hannon WH, et al.: Iodine nutrition in the United States. Trends and public health implications: Iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab 1998; 83: 3401-8.